Antiarrhythmic Pharmacology and Patient Management - VIDEO
Antiarrhythmic pharmacology is an important aspect of patient management in those with both atrial arrhythmias and also in those with life threatening ventricular arrhythmias. A fresh look at antiarrhythmic pharmacology will be presented, to help you understand the mechanism of action, as well as potential adverse effects.  Pharmacology will be linked to both the cardiac rhythm disturbance, as well as to patient characteristics, to create a holistic perspective regarding antiarrhythmic pharmacology.
Seminar Information
Seminar Date:
January 14, 2010
Seminar Objectives
  • Explain why electrolyte abnormalities can enhance the risk of adverse effects with antiarrhythmic therapy.
  • Describe why amiodarone is better tolerated than many other antiarrhythmics in patients with reduced left ventricular function.
  • Correlate antiarrhythmic pharmacology to the phase of the action potential where the drug exerts its action.
Antiarrhythmic Pharmacology and Patient Management
  • Class I Agents
    • Class I A
    • Class I B
    • Class I C
    • Mechanism of action / electrolyte impact
    • Side effects
    • Nursing considerations
  • Class II Agents
    • Mechanism of action / electrolyte impact
    • Side effects
    • Nursing considerations
  • Class III Agents
    • Mechanism of action
    • Side effects
    • Nursing considerations
  • Class IV Agents
    • Mechanism of action
    • Side effects
    • Nursing considerations
  • Action of medications based on phase of cardiac action potential Potential complications and patient education related to specific antiarrhythmic therapy
    • Short term / immediate responses
    • Long term management issues
Speaker Information
Karen M. Marzlin MSN, RN, CCNS, CCRD-CMC   [ view bio ]
American Nurses Credentialing Center’s Commission on Accreditation
Contact Hour: 1.00
PESI, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses completing these materials will earn 1.0 contact hour.
California Board of Registered Nursing
Contact Hour: 1.00
PESI, LLC is a provider approved by the California Board of Registered Nursing, Provider Number 6538 for 1.0 contact hour.
Iowa Board of Nursing
Contact Hour: 1.00
PESI, LLC, is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses completing these materials will earn 1.0 contact hour.
Florida Board of Nursing
Contact Hour: 1.00
PESI, LLC, is an approved provider by the Florida Board of Nursing. Provider #: 50-1586. These materials qualify for 1.0 contact hour.
Cardiovascular Credentialing International
Contact Hour: 1.00
Cardiovascular Credentialing International (CCI) recognizes programs and providers approved by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). This course will qualify for 1.0 contact hour.
Preview
On-Line Subscription
You must be logged in to access PESIHealthcare On-Line Subscriptions.
To continue, please log on.
Email:
Password:
Products
Streaming
PESIHealthcare Price:$39.00
Podcast
PESIHealthcare Price:$39.00